false
0001582982
0001582982
2025-07-24
2025-07-24
0001582982
CCLD:CommonStockParValue0.001PerShareMember
2025-07-24
2025-07-24
0001582982
CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember
2025-07-24
2025-07-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 24, 2025
CARECLOUD,
INC.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-36529 |
|
22-3832302 |
(State or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS Employer
Identification No.) |
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CCLD |
|
Nasdaq
Global Market |
| 8.75%
Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share |
|
CCLDO |
|
Nasdaq
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure.
The
Registrant is hereby furnishing the following information under Regulation FD:
On
July 25, 2025, the Registrant issued a press release announcing that its Board of Directors declared monthly cash dividends for its Series
A Cumulative Redeemable Perpetual Preferred Stock and its Series B Cumulative Redeemable Perpetual Preferred Stock for July, August and
September 2025.
The
foregoing description of the dividend payment does not purport to be complete and is explained in the press release, attached as Exhibit
99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Safe
Harbor Statement
Statements
contained in the exhibit that state the Company’s or its management’s expectations or predictions of the future are forward-looking
statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended, and the Securities Exchange
Act of 1934, as amended. It is important to note that the Registrant’s actual results could differ materially from those projected
in such forward-looking statements. The Registrant does not assume any obligations to update any of the forward-looking statements contained
in the exhibit to reflect events that occur or circumstances that exist after the date on which they were made.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| 99.1 |
Press release dated July 25, 2025. |
| |
|
| 104 |
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
|
CareCloud,
Inc. |
| |
|
|
| Date: |
July
25, 2025 |
By:
|
/s/
Norman Roth |
| |
|
|
Norman
Roth |
| |
|
|
Interim
Chief Financial Officer and Corporate Controller |
